{"id":"W2134021845","doi":"10.1016/s1470-2045(11)70338-2","title":"Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Juravinski Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Aflibercept; Paracentesis; Ascites; Placebo; Surgery; Population; Clinical endpoint; Internal medicine; Ovarian cancer; Chemotherapy; Bevacizumab; Gastroenterology; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004514544,0.0003173487,0.001987224,0.0001398281,0.00007167675,0.000008071747,0.0001523135,0.00008454267,0.000165281],"category_scores_gemma":[0.00002386323,0.0001641222,0.0001580803,0.0001974993,0.00009571074,0.00004631126,0.00002079512,0.00007885139,0.000004015928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006724789,"about_ca_system_score_gemma":0.0003499111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004601215,"about_ca_topic_score_gemma":0.001266563,"domain_scores_codex":[0.9980509,0.0002319905,0.0006533118,0.0003998238,0.0002061753,0.0004578171],"domain_scores_gemma":[0.9983747,0.0004189766,0.0004376697,0.0005174116,0.0001435668,0.0001076821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7969387,0.02803065,0.04242408,0.00008125244,0.001717501,0.00003953572,0.009726483,0.00002027061,0.00001359312,0.0001192581,0.00004216867,0.1208466],"study_design_scores_gemma":[0.8893374,0.05391699,0.05309407,0.0001831985,0.00183,0.000005439174,0.0005373101,0.00006966141,0.0004106279,0.00005407128,0.0004017199,0.0001595613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798348,0.0005286366,0.00004844615,0.0007050807,0.0002671752,0.01791299,0.00006733073,0.00003107901,0.0006044658],"genre_scores_gemma":[0.9842626,0.0004485505,0.0010731,0.0001133817,0.0001509607,0.01382263,0.00004053133,0.00003478335,0.00005346296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.120687,"threshold_uncertainty_score":0.6692709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06439106428427824,"score_gpt":0.3562637120626185,"score_spread":0.2918726477783403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}